NCT00006048View on ClinicalTrials.gov

ZD 1839 Plus Combination Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer

PHASE3UnknownINTERVENTIONAL

Timeline

Start Date

May 31, 2000

Conditions

Lung Cancer

Interventions

DRUG

cisplatin

DRUG

gefitinib

DRUG

gemcitabine hydrochloride

Trial Locations (1)

19850-5437

AstraZeneca Pharmaceuticals LP, Wilmington

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY